Zopapogene imadenovec

伊艾泽帕基

Report date: 2026/04/27 20:02:09
First In Class

Base Information

Drug NameZopapogene imadenovec
Drug Alias NamePapzimeosPRGN-2012
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector > Gorilla adenovirus vector (strain GC46)Vaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory papillomatosisPapillomavirus Infections
Global Approved IndicationsRespiratory papillomatosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/08/14
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPrecigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrecigen Inc
Inactive CompaniesN/A
Active IndicationsRespiratory papillomatosisPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A